VIM and non-small cell lung carcinoma: In monocultures, treatment with anti-GPC1 mAb had no effect on the levels of phosphorylated signaling effectors and the protein expression of GPC1, β-catenin and vimentin proteins in A549 and H460 NSCLC cell lines (Figure 4).